Last reviewed · How we verify

NCT03634163: WECCC-NHB

Compassionate Communities Neighbourhood Program

Status unknown NA Last updated 16 August 2018
What this trial tests

NA trial testing Neighbourhood exchange in Chronic Disease in 1,000 participants. Status unknown.

Timeline
1 September 2018
Primary endpoint
31 March 2020
31 March 2021

Quick facts

Lead sponsorMcMaster University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment1,000
Start date1 September 2018
Primary completion31 March 2020
Estimated completion31 March 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

McMaster University

Who can join

18 and older, any sex, with Chronic Disease or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate a Compassionate Communities-based intervention aimed at reducing social isolation by mobilizing individuals to act on their health and social needs individually, and in collaboration with fellow members of their community. The intervention program includes facilitated building of neighbourhood networks (member benefits include access to practical help, the opportunity to develop meaningful relationships, and community mobilization), and coaching support to work on individualized goal setting and more detailed navigation support and planning.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Disease

Currently open trials in the same condition.

Other McMaster University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03634163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing